Skip to main content
SpringerLink
Log in

Cutaneous Lesions that Mimic Infection in Transplant Patients

  • Chapter
  • First Online:
Principles and Practice of Transplant Infectious Diseases

  • 1600 Accesses

Abstract

Dermatologists are often called upon to evaluate skin lesions in organ transplant patients, especially when an infectious etiology is suspected. This section will review some of the non-infectious skin eruptions that mimic cutaneous infections. This chapter is intended to help the clinician generate a differential diagnosis when evaluating cutaneous lesions in organ transplant patients. Using the morphology of the primary lesion as a starting point, we then list the non-infectious diagnosis that could be considered and the infectious process it mimics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Urano S, Kodama H, Kato K, Nogura K. Pyoderma gangrenosum with systemic involvement. J Dermatol. 1995;22(7):515–9.

    Article  CAS  PubMed  Google Scholar 

  2. Hurwitz RM, Haseman JH. The evolution of pyoderma gangrenosum. A clinicopathologic correlation. Am J Dermatopathol. 1993;15(1):28–33.

    Article  CAS  PubMed  Google Scholar 

  3. Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790–800.

    Article  PubMed  Google Scholar 

  4. Callen JP. Pyoderma gangrenosum. Lancet. 1998;351(9102):581–5.

    Article  CAS  PubMed  Google Scholar 

  5. Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33(4):787–802, vi.

    Article  PubMed  Google Scholar 

  6. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996;34(3):395–409; quiz 410–2.

    Article  CAS  PubMed  Google Scholar 

  7. Emmi L, Brugnolo F, Salvati G, et al. Immunopathological aspects of Behcet’s disease. Clin Exp Rheumatol. 1995;13(6):687–91.

    CAS  PubMed  Google Scholar 

  8. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007;48(4):573–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42(10):761–78.

    Article  PubMed  Google Scholar 

  10. von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31(4):535–56.

    Article  PubMed  Google Scholar 

  11. Cohen PR, Kurzrock R. Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol. 2000;18(3):265–82.

    Article  CAS  PubMed  Google Scholar 

  12. Kennedy C. The spectrum of inflammatory skin disease following jejuno-ileal bypass for morbid obesity. Br J Dernatol. 1981;105(4):425–35.

    Article  CAS  Google Scholar 

  13. Ely P. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol. 1980;2(6):473–87.

    Article  CAS  PubMed  Google Scholar 

  14. Revuz J, Valeyrie-Allanore L. Drug reactions. In: Bolognia J, Lorizzo JL, Rapini RP, Callen JP, Horn TD, Mancini AJ, et al., editors. Dermatology. Mosby: Elsevier; 2008. p. 301–20.

    Google Scholar 

  15. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 1991;127(9):1333–8.

    Article  CAS  PubMed  Google Scholar 

  16. Ramdial PK, Naidoo DK. Drug-induced cutaneous pathology. J Clin Pathol. 2009;62(60):493–504.

    Article  CAS  PubMed  Google Scholar 

  17. James WD. Clinical practice. Acne. N Engl J Med. 2005;352(14):1463–72.

    Article  CAS  PubMed  Google Scholar 

  18. Wnorowski AM, de Souza A, Chachoua A, Cohen DE. The management of EGFR inhibitor adverse events: a case series and treatment paradigm. Int J Dermatol. 2012;51(2):223–32.

    Article  CAS  PubMed  Google Scholar 

  19. Nervi SJ, Schwartz RA, Dmochowski M. Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol. 2006;55(2):285–9.

    Article  PubMed  Google Scholar 

  20. Fraser SJ, Benton EC, Roddie PH, Krajewski AS, Goodlad JR. Eosinophilic folliculitis: an important differential diagnosis after allogeneic bone-marrow transplant. Clin Exp Dermatol. 2009;34(3):369–71.

    Article  CAS  PubMed  Google Scholar 

  21. Fukamachi S, Kabashima K, Sugita K, Kobayashi M, Tokura Y. Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis. Acta Derm Venereol. 2009;89(2):155–9.

    CAS  PubMed  Google Scholar 

  22. Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol. 1998;38(1):1–17.

    Article  CAS  PubMed  Google Scholar 

  23. Mowad CM, McGinley KJ, Foglia A, Leyden JJ. The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol. 1995;33(5. Pt 1):729–33.

    Article  CAS  PubMed  Google Scholar 

  24. Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol. 2008;59(3):524–9.

    Article  PubMed  Google Scholar 

  25. Cohen PR. Neutrophilic dermatoses occurring in oncology patients. Int J Dermatol. 2007;46(1):106–11.

    Article  PubMed  Google Scholar 

  26. Alley E, Green R, Schuchter L. Cutaneous toxicities of cancer therapy. Curr Opin Oncol. 2002;14(2):212–6.

    Article  CAS  PubMed  Google Scholar 

  27. Kim BS, Kim WJ, Ko HC, Kim MB, Kim DW, Kim JM. Features of Staphylococcus aureus colonization in patients with nummular eczema. Br J Dermatol. 2013;168(3):658–60.

    Article  CAS  PubMed  Google Scholar 

  28. Lin SS, Tsai TH, Yang HH. Rare cutaneous side-effect of gefitinib masquerading as superficial dermatophytosis. Clin Exp Dermatol. 2009;34(4):528–30.

    Article  PubMed  Google Scholar 

  29. Wolf R, Oumeish OY, Parish LC. Intertriginous eruption. Clin Dermatol. 2011;29(2):173–9.

    Article  PubMed  Google Scholar 

  30. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26(13):2085–92.

    Article  PubMed  Google Scholar 

  31. Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006;54(1):28–46.

    Article  PubMed  Google Scholar 

  32. Hill A, Hanson M, Bogle MA, Duvic M. Severe radiation dermatitis is related to Staphylococcus aureus. Am J Clin Oncol. 2004;27(4):361–3.

    Article  PubMed  Google Scholar 

  33. Johnson MA, Armstrong AW. Clinical and histologic diagnostic guidelines for psoriasis: a critical review. Clin Rev Allergy Immunol. 2013;44(2):166–72.

    Article  PubMed  Google Scholar 

  34. Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009;61(2):303–18.

    Article  PubMed  Google Scholar 

  35. Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine (Baltimore). 1998;77(6):403–18. (review).

    CAS  Google Scholar 

  36. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial. 2002;15(3):172–86.

    Article  PubMed  Google Scholar 

  37. Fischer AH, Morris DJ. Pathogenesis of calciphylaxis: study of three cases with literature review. Hum Pathol. 1995;26:1055.

    Article  CAS  PubMed  Google Scholar 

  38. Hussein MR, Ali HO, Abdulwahed SR, Argoby Y, Tobeigei FH. Calciphylaxis cutis: a case report and review of literature. Exp Mol Pathol. 2009;86(2):134–5.

    Article  CAS  PubMed  Google Scholar 

  39. Buckingham SC, Marshall GS, Schutze GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007;150(2):180–4, 184.e1.

    Article  PubMed  Google Scholar 

  40. Winkelmann RK. Panniculitis in connective tissue disease. Arch Dermatol. 1983;119:336.

    Article  CAS  PubMed  Google Scholar 

  41. Friedman PC, Husain S, Grossman ME. Nodular tuberculid in a patient with HIV. J Am Acad Dermatol. 2005;53(2. Suppl 1):S154–6.

    Article  PubMed  Google Scholar 

  42. Fernandes SS, Carvalho J, Leite S, Afonso M, Pinto J, Veloso R, et al. Erythema induratum and chronic hepatitis C infection. J Clin Virol. 2009;44(4):333–6.

    Article  PubMed  Google Scholar 

  43. Ugurel S, Lahaye T, Hildenbrand R, Glorer E, Reiter A, Hochhaus A, et al. Panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib. Br J Dermatol. 2003;149(3):678–9.

    Article  CAS  PubMed  Google Scholar 

  44. Assouline S, Laneuville P, Gambacorti-Passerini C. Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia. N Engl J Med. 2006;354(24):2623.

    Article  CAS  PubMed  Google Scholar 

  45. Ball NJ, Adams SP, Marx LH, et al. Possible origin ofpancreatic fat necrosis as a septal panniculitis. J Am Acad Dermatol. 1996;34:362–4.

    Article  CAS  PubMed  Google Scholar 

  46. Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101(5):1012–23.

    Article  PubMed  Google Scholar 

  47. Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010;23:375–88.

    Article  PubMed  Google Scholar 

  48. Herouy Y, May AE, Pornschlegel G, Stetter C, Grenz H, Preissner KT, et al. Lipodermatosclerosis is characterized by elevated expression and activation on matrix metalloproteinases: implications for venous ulcer formation. J Invest Dermatol. 1998;111:822–7.

    Article  CAS  PubMed  Google Scholar 

  49. Cantwell AR Jr, Martz W. Idiopathic bullae in diabetics. Bullosis diabeticorum. Arch Dermatol. 1967;96:42–4.

    Article  PubMed  Google Scholar 

  50. Larrey D. Memoires de Chirurgie Militaire et Campagnes. Paris: Smith and Buisson; 1812.

    Google Scholar 

  51. Groschel D, Gerstein AR, Rosenbaum JM. Skin lesions as a diagnostic aid in barbiturate poisoning. N Engl J Med. 1970;283:409–10.

    Article  CAS  PubMed  Google Scholar 

  52. Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol. 1998;38:1–17. quiz 8–20.

    Article  CAS  PubMed  Google Scholar 

  53. Herschthal D, Robinson MJ. Blisters of the skin in coma induced by amitriptyline and clorazepate dipotassium. Report of a case with underlying sweat gland necrosis. Arch Dermatol. 1979;115:499.

    Article  CAS  PubMed  Google Scholar 

  54. Varma AJ, Fisher BK, Sarin MK. Diazepam-induced coma with bullae and eccrine sweat gland necrosis. Arch Intern Med. 1977;137:1207–10.

    Article  CAS  PubMed  Google Scholar 

  55. Judge TG, Nisbet NH. Trophoneurotic blisters in elderly hemiplegics. Lancet. 1967;1:811–2.

    Article  CAS  PubMed  Google Scholar 

  56. Raymond LW. “Barbiturate blisters” in a case of severe hypoglycaemic coma. Lancet. 1972;2:764.

    Article  CAS  PubMed  Google Scholar 

  57. Mehregan DR, Daoud M, Rogers RS 3rd. Coma blisters in a patient with diabetic ketoacidosis. J Am Acad Dermatol. 1992;27:269–70.

    Article  CAS  PubMed  Google Scholar 

  58. Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009;9:316–21.

    Article  PubMed  Google Scholar 

  59. Teraki Y, Moriya N, Shiohara T. Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. Am J Pathol. 1994;145:550–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Ramdial PK, Naidoo DK. Drug-induced cutaneous pathology. J Clin Pathol. 2009;62:493–504.

    Article  CAS  PubMed  Google Scholar 

  61. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–8.

    CAS  PubMed  Google Scholar 

  62. Hymes SR, Alousi AM, Cowen EW. Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease. J Am Acad Dermatol. 2012;66:515 e1–e18.

    Article  Google Scholar 

  63. Schauder CS, Hymes SR, Rapini RP, Zipf TF. Vesicular graft-versus-host disease. Int J Dermatol. 1992;31:509–10.

    Article  CAS  PubMed  Google Scholar 

  64. Moreno JC, Valverde F, Martinez F, Velez A, Torres A, Fanego J, et al. Bullous scleroderma-like changes in chronic graft-versus-host disease. J Eur Acad Dermatol Venereol. 2003;17:200–3.

    Article  CAS  PubMed  Google Scholar 

  65. Hymes SR, Farmer ER, Burns WH, Morison WL, Tutschka PJ, Walters LL, et al. Bullous sclerodermalike changes in chronic graft-vs-host disease. Arch Dermatol. 1985;121:1189–92.

    Article  CAS  PubMed  Google Scholar 

  66. McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983;19:205–66.

    Article  CAS  PubMed  Google Scholar 

  67. Daoud MS, Gibson LE, Daoud S, el-Azhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc. 1995;70:559–64.

    Article  CAS  PubMed  Google Scholar 

  68. Hogan D, Card RT, Ghadially R, McSheffrey JB, Lane P. Human immunodeficiency virus infection and porphyria cutanea tarda. J Am Acad Dermatol. 1989;20:17–20.

    Article  CAS  PubMed  Google Scholar 

  69. Green JJ, Manders SM. Pseudoporphyria. J Am Acad Dermatol. 2001;44:100–8.

    Article  CAS  PubMed  Google Scholar 

  70. Phung TL, Pipkin CA, Tahan SR, Chiu DS. Beta-lactam antibiotic-induced pseudoporphyria. J Am Acad Dermatol. 2004;51:S80–2.

    Article  PubMed  Google Scholar 

  71. Degiovanni CV, Darley CR. Pseudoporphyria occurring during a course of ciprofloxacin. Clin Exp Dermatol. 2008;33:109–10.

    CAS  PubMed  Google Scholar 

  72. Kwong WT, Hsu S. Pseudoporphyria associated with voriconazole. J Drugs Dermatol. 2007;6:1042–4.

    PubMed  Google Scholar 

  73. Epstein JH, Seibert JS. Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensitization. Arch Dermatol. 1976;112:661–6.

    Article  CAS  PubMed  Google Scholar 

  74. Alcalay J, David M, Ingber A, Hazaz B, Sandbank M. Bullous pemphigoid mimicking bullous erythema multiforme: an untoward side effect of penicillins. J Am Acad Dermatol. 1988;18:345–9.

    Article  CAS  PubMed  Google Scholar 

  75. Czechowicz RT, Reid CM, Warren LJ, Weightman W, Whitehead FJ. Bullous pemphigoid induced by cephalexin. Australas J Dermatol. 2001;42:132–5.

    Article  CAS  PubMed  Google Scholar 

  76. Kimyai-Asadi A, Usman A, Nousari HC. Ciprofloxacin-induced bullous pemphigoid. J Am Acad Dermatol. 2000;42:847.

    Article  CAS  PubMed  Google Scholar 

  77. Nousari HC, Deterding R, Wojtczack H, Aho S, Uitto J, Hashimoto T, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med. 1999;340:1406–10.

    Article  CAS  PubMed  Google Scholar 

  78. Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol. 1998;16:393–7.

    Article  CAS  PubMed  Google Scholar 

  79. Yeh SW, Ahmed B, Sami N. Razzaque Ahmed A. Blistering disorders: diagnosis and treatment. Dermatol Ther. 2003;16:214–23.

    Article  CAS  PubMed  Google Scholar 

  80. Blenkinsopp WK, Haffenden GP, Fry L, Leonard JN. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid. Am J Dermatopathol. 1983;5:547–54.

    Article  CAS  PubMed  Google Scholar 

  81. Rosen LB, Frank BL, Rywlin AM. A characteristic vesiculobullous eruption in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 1986;15:943–50.

    Article  CAS  PubMed  Google Scholar 

  82. Ajithkumar K, George S, Babu PG. Abnormal insect bite reactions: a manifestation of immunosuppression of HIV infection? Indian J Dermatol Venereol Leprol. 2001;67:72–4.

    CAS  PubMed  Google Scholar 

  83. Byrd JB, Woodard-Grice A, Stone E, Lucisano A, Schaefer H, Yu C, et al. Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use. Allergy. 2010;65:1381–7.

    Article  CAS  PubMed  Google Scholar 

  84. Choy AC, Yarnold PR, Brown JE, Kayaloglou GT, Greenberger PA, Patterson R. Virus induced erythema multiforme and Stevens-Johnson syndrome. Allergy Proc. 1995;16:157–61.

    Article  CAS  PubMed  Google Scholar 

  85. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019–24.

    Article  PubMed  Google Scholar 

  86. Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management. Ann Med. 2008;40:129–38.

    Article  PubMed  Google Scholar 

  87. French LE, Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia J, Rapini R, editors. Dermatology. St. Louis, MO: Mosby Elsevier; 2008. p. 288.

    Google Scholar 

  88. Geria AN, Holcomb KZ, Scheinfeld NS. Necrolytic acral erythema: a review of the literature. Cutis. 2009;83:309–14.

    PubMed  Google Scholar 

  89. Dabski K, Winkelmann RK. Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol. 1989;20:39–47.

    Article  CAS  PubMed  Google Scholar 

  90. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011;65:263–79. quiz 80

    Article  Google Scholar 

  91. Lott DG, Manz R, Koch C, Lorenz RR. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients. Transplantation. 2010;90:683–7.

    Article  PubMed  Google Scholar 

  92. Bangash HK, Colegio OR. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients. Curr Treat Options Oncol. 2012;13(3):354–76.

    Article  PubMed  Google Scholar 

  93. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681–91.

    Article  PubMed  Google Scholar 

  94. Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, Touraine JL, Faure M, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol. 1995;33:222–9.

    Article  CAS  PubMed  Google Scholar 

  95. Euvrard S, Chardonnet Y, Pouteil-Noble C, Kanitakis J, Chignol MC, Thivolet J, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer. 1993;72:2198–206.

    Article  CAS  PubMed  Google Scholar 

  96. Hollenbeak CS, Todd MM, Billingsley EM, Harper G, Dyer AM, Lengerich EJ. Increased incidence of melanoma in renal transplantation recipients. Cancer. 2005;104:1962–7.

    Article  PubMed  Google Scholar 

  97. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125:1747–54.

    Article  CAS  PubMed  Google Scholar 

  98. Miller DD, Cowen EW, Nguyen JC, McCalmont TH, Fox LP. Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity. Arch Dermatol. 2010;146(3):300–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Scerri L, Williams HC, Allen BR. Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol. 1996;134:1105–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Ana Ciurea & Sharon Hymes

Authors
  1. Ana Ciurea
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon Hymes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ana Ciurea .

Editor information

Editors and Affiliations

  1. Clinical Associate Professor of Medicine, Texas Tech University Health Sciences Center El Paso, Paul L. Foster School of Medicine, El Paso, TX, USA

    Amar Safdar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ciurea, A., Hymes, S. (2019). Cutaneous Lesions that Mimic Infection in Transplant Patients. In: Safdar, A. (eds) Principles and Practice of Transplant Infectious Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-9034-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9034-4_23

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-9032-0

  • Online ISBN: 978-1-4939-9034-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation